臨床基因體學暨蛋白質體學碩士學位學程

研究成果

每年研究成果 1990 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

• 54637 引文
• 87 h-指數
• 2530 文章
• 82 回顧型文獻
• 46 評論/辯論
• 33 會議貢獻
• 72 更多
  • 20 章節
  • 14 書籍
  • 14 快報
  • 6 社論
  • 6 專利
  • 4 摘要
  • 2 Erratum
  • 1 選集
  • 1 章節（同行評審）
  • 1 其他
  • 1 論文
  • 1 海报
  • 1 簡短的問卷調查

每年研究成果

每年研究成果

搜尋結果

• 文章

  A novel composite hydrogel composed of formic acid-decellularized pepsin-soluble extracellular matrix hydrogel and sacchachitin hydrogel as wound dressing to synergistically accelerate diabetic wound healing

  Hsieh, C. M., Wang, W., Chen, Y. H., Wei, P. S., Liu, Y. H., Sheu, M. T. & Ho, H. O., 6月 11 2020, 於: Pharmaceutics. 12, 6, p. 1-18 18 p., 538.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • formic acid 100%
  • Pepsin A 96%
  • Hydrogels 83%
  • Bandages 81%
  • Wound Healing 68%
  12 引文 斯高帕斯（Scopus）

• A novel compound heterozygous mutation of K494_V495 deletion plus R496L and D487_F489 deletion in extreme C-terminus of cytochrome P450c17 causes 17α-hydroxylase deficiency

  Lee, L. S., Shu, W. J., Wu, C. M., Hsieh, C. H., Chen, S. M., Hu, C. J., Chen, W. Y. & Chung, B. C., 4月 25 2006, 於: Molecular and Cellular Endocrinology. 249, 1-2, p. 16-20 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Steroid 17-alpha-Hydroxylase 100%
  • Cytochromes 78%
  • Mixed Function Oxygenases 77%
  • Cytochrome 59%
  • Mutation 58%
  12 引文 斯高帕斯（Scopus）

• A novel dual HDAC6 and tubulin inhibitor, MPT0B451, displays anti-tumor ability in human cancer cells in vitro and in vivo

  Wu, Y. W., Hsu, K. C., Lee, H. Y., Huang, T. C., Lin, T. E., Chen, Y. L., Sung, T. Y., Liou, J. P., Hwang-Verslues, W. W., Pan, S. L. & HuangFu, W. C., 3月 13 2018, 於: Frontiers in Pharmacology. 9, MAR, 205.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Tubulin Modulators 100%
  • In Vitro Techniques 26%
  • Tubulin 26%
  • Histone Deacetylase 6 19%
  • Neoplasms 19%
  21 引文 斯高帕斯（Scopus）

• A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo

  Wu, Y. W., Chao, M. W., Tu, H. J., Chen, L. C., Hsu, K. C., Liou, J. P., Yang, C. R., Yen, S. C., HuangFu, W. C. & Pan, S. L., 5月 2021, 於: Oncogenesis. 10, 5, 39.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Histone Deacetylase Inhibitors 100%
  • Leukemia 69%
  • Down-Regulation 59%
  • In Vitro Techniques 37%
  • Mitogen-Activated Protein Kinase Kinases 23%
  7 引文 斯高帕斯（Scopus）

• A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation

  Lee, H. Y., Tang, D. W., Liu, C. Y. & Cho, E. C., 1月 25 2022, 於: Chemico-Biological Interactions. 352, 109778.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Apoptosis Induction 100%
  • Histone 73%
  • Antitumor 62%
  • Safety 58%
  • Colorectal Neoplasms 54%
  2 引文 斯高帕斯（Scopus）

• A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling

  Chang, T. Y., Nepali, K., Chen, Y. Y., Yang, Y. C. S. H., Hsu, K. C., Yen, Y., Pan, S. L., Liou, J. P. & Lee, S. B., 6月 2021, 於: Biomedicine and Pharmacotherapy. 138, 111485.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Histone Deacetylase Inhibitors 100%
  • Histone Deacetylases 99%
  • Cell Cycle Checkpoints 83%
  • Mitosis 28%
  • Epigenomics 24%
  3 引文 斯高帕斯（Scopus）

• A novel lung alveolar cell model for exploring volatile biomarkers of particle-induced lung injury

  Chuang, H. C., Tsai, S. W., Shie, R. H., Lu, Y. C., Song, S. R., Huang, S. H., Peng, H. Y. & Yang, H. Y., 12月 1 2020, 於: Scientific Reports. 10, 1, 15700.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Alveolar Epithelial Cells 100%
  • Lung Injury 93%
  • Quartz 92%
  • octane 73%
  • Alkanes 66%

• A novel microtubule-disrupting agent induces endoplasmic reticular stress-mediated cell death in human hepatocellular carcinoma cells

  Ho, C. T., Chang, Y. J., Yang, L. X., Wei, P. L., Liu, T. Z. & Liu, J. J., 9月 10 2015, 於: PLoS One. 10, 9, e0136340.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • hepatoma 100%
  • Cell Death 97%
  • Microtubules 88%
  • microtubules 86%
  • cell death 84%
  12 引文 斯高帕斯（Scopus）

• A novel preventive mechanism of gentamicin-induced nephrotoxicity by atorvastatin

  Lee, M. C., Cheng, K. J., Chen, S. M., Li, Y. C., Imai, K., Lee, C. M. & Lee, J. A., 11月 1 2019, 於: Biomedical Chromatography. 33, 11, p. e4639 e4639.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Atorvastatin 100%
  • Gentamicins 70%
  • Cathepsins 34%
  • Pharmacological Metabolism 20%
  • Isoprenoid 17%
  6 引文 斯高帕斯（Scopus）

• A novel RING finger protein, Znf179, modulates cell cycle exit and neuronal differentiation of P19 embryonal carcinoma cells

  Pao, P. C., Huang, N. K., Liu, Y. W., Yeh, S. H., Lin, S. T., Hsieh, C. P., Huang, A. M., Huang, H. S., Tseng, J. T., Chang, W. C. & Lee, Y. C., 11月 2011, 於: Cell Death and Differentiation. 18, 11, p. 1791-1804 14 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Embryonal Carcinoma Stem Cells 100%
  • Cell Cycle 57%
  • Proteins 26%
  • Cell Cycle Checkpoints 20%
  • Cell Differentiation 16%
  28 引文 斯高帕斯（Scopus）

• A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase i

  Yu, C. C., Pan, S. L., Chao, S. W., Liu, S. P., Hsu, J. L., Yang, Y. C., Li, T. K., Huang, W. J. & Guh, J. H., 8月 1 2014, 於: Biochemical Pharmacology. 90, 3, p. 320-330 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • N-hydroxy-6-(4-carbamoylacridinyl)hexanamide 100%
  • Vorinostat 67%
  • Histone Deacetylases 45%
  • Histone 41%
  • Human Activities 38%
  24 引文 斯高帕斯（Scopus）

• A novel SNP in the 5' regulatory region of organic anion transporter 1 is associated with chronic kidney disease

  Sun, C. Y., Wu, M. S., Lee, C. C., Chen, S. H., Lo, K. C. & Chen, Y. H., 12月 1 2018, 於: Scientific Reports. 8, 1, 8085.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Organic Anion Transporters 100%
  • Nucleic Acid Regulatory Sequences 80%
  • Chronic Renal Insufficiency 63%
  • Single Nucleotide Polymorphism 58%
  • hepatoma-derived growth factor 41%
  11 引文 斯高帕斯（Scopus）

• A novel tool for visualizing chronic kidney disease associated polymorbidity: A 13-year cohort study in Taiwan

  Huang, C. W., Syed-Abdul, S., Jian, W. S., Iqbal, U., Nguyen, P. A. A. L., Lee, P., Lin, S. H., Hsu, W. D., Wu, M. S., Wang, C. F., Ma, K. L. & Li, Y. C. J. A., 3月 1 2015, 於: Journal of the American Medical Informatics Association. 22, 2, p. 290-298 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Taiwan 100%
  • Chronic Renal Insufficiency 92%
  • Cohort Studies 68%
  • Comorbidity 33%
  • National Health Programs 15%
  23 引文 斯高帕斯（Scopus）

• Anti-apoptotic gene delivery with cyclo-(D-Trp-Tyr) peptide nanotube via eye drop following corneal epithelial debridement

  Lee, Y. H., Chang, S. F. & Liaw, J., 7月 17 2015, 於: Pharmaceutics. 7, 3, p. 122-136 15 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • tryptophyltyrosine 100%
  • Peptide Nanotubes 89%
  • Peptide Nanotube 65%
  • Eye Drop 62%
  • Antiapoptotic 60%
  10 引文 斯高帕斯（Scopus）

• Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo

  Huang, H-L., Lee, H. Y., Tsai, A-C., Peng, C-Y., Lai, M-J., Wang, J-C., Pan, S. L., Teng, C-M. & Liou, J. P., 8月 22 2012, 於: PLoS ONE. 7, 8, e43645.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • 3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 100%
  • histone deacetylase 58%
  • HCT116 Cells 55%
  • colorectal neoplasms 52%
  • Histone Deacetylase Inhibitors 49%
  31 引文 斯高帕斯（Scopus）

• Anticancer Effects of Taiwanofungus camphoratus Extracts, Isolated Compounds and its Combinational use

  Chen, Y. C., Ho, H. O., Su, C. H. & Sheu, M. T., 12月 2010, 於: Journal of Experimental and Clinical Medicine(Taiwan). 2, 6, p. 274-281 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Taiwan 100%
  • Succinates 94%
  • maleic acid 72%
  • Mycelium 68%
  • Lovastatin 67%
  22 引文 斯高帕斯（Scopus）

• Anticataractogenesis Mechanisms of Curcumin and a Comparison of Its Degradation Products: An in Vitro Study

  Liao, J. H., Huang, Y. S., Lin, Y. C., Huang, F. Y., Wu, S. H. & Wu, T. H., 3月 16 2016, 於: Journal of Agricultural and Food Chemistry. 64, 10, p. 2080-2086 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • curcumin 100%
  • Curcumin 88%
  • in vitro studies 75%
  • Degradation Product 72%
  • degradation 46%
  8 引文 斯高帕斯（Scopus）

• Antihyperlipidemic and antioxidant effects of C-phycocyanin in golden syrian hamsters fed with a hypercholesterolemic diet

  Sheu, M. J., Hsieh, Y. Y., Lai, C. H., Chang, C. C. & Wu, C. H., 2013, 於: Journal of Traditional and Complementary Medicine. 3, 1, p. 41-47 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Phycocyanin 100%
  • Hypolipidemic Agents 80%
  • Mesocricetus 72%
  • Antioxidants 44%
  • Diet 41%
  25 引文 斯高帕斯（Scopus）

• Anti-inflammatory and free radial scavenging activities of the constituents isolated from machilus zuihoensis

  Mao, Y. W., Tseng, H. W., Liang, W. L., Chen, I. S., Chen, S. T. & Lee, M. H., 11月 2011, 於: Molecules. 16, 11, p. 9451-9466 16 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • ethyl caffeate 100%
  • scavenging 66%
  • nitric oxide 61%
  • Antiinflammatory 48%
  • inorganic peroxides 47%
  21 引文 斯高帕斯（Scopus）

• Anti-Inflammatory mechanisms of the proteinase-activated receptor 2-inhibiting peptide in human synovial cells

  Chen, T-L., Lin, Y-F., Cheng, C-W., Chen, S. Y., Sheu, M-T., Leung, T-K., Qin, C. H. & Chen, C-H., 2011, 於: Journal of Biomedical Science. 18, 1, 43.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • PAR-2 Receptor 100%
  • Antiinflammatory 66%
  • Anti-Inflammatory Agents 51%
  • Peptides 44%
  • Cyclooxygenase 2 40%
  8 引文 斯高帕斯（Scopus）

• Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy

  Liao, P. L., Lin, C. H., Li, C. H., Tsai, C. H., Ho, J. D., Chiou, G. C. Y., Kang, J. J. & Cheng, Y. W., 3月 21 2017, 於: Scientific Reports. 7, 44985.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • diabetic retinopathy 100%
  • shikonin 94%
  • anti-inflammatory activity 63%
  • hypoxia 55%
  • retinal diseases 35%
  33 引文 斯高帕斯（Scopus）

• Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo

  Hsieh, Y. L., Tu, H. J., Pan, S. L., Liou, J. P. & Yang, C. R., 6月 1 2019, 於: Biochimica et Biophysica Acta - Molecular Cell Research. 1866, 6, p. 992-1003 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Histone Deacetylase 6 100%
  • Triple Negative Breast Neoplasms 74%
  • Histone Deacetylase Inhibitors 72%
  • Breast Neoplasms 39%
  • Acetylation 27%
  26 引文 斯高帕斯（Scopus）

• Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae

  Lin, R. D., Chin, Y. P. & Lee, M. H., 7月 2005, 於: Phytotherapy Research. 19, 7, p. 612-617 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Klebsiella pneumoniae 100%
  • Flavonoids 95%
  • Flavonoid 89%
  • Ampicillin 88%
  • Clavulanate 82%
  53 引文 斯高帕斯（Scopus）

• Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes

  Lee, H. Y., Chang, C-Y., Lai, M-J., Chuang, H-Y., Kuo, C-C., Chang, C-Y., Chang, J-Y. & Liou, J. P., 7月 23 2015, 於: Bioorganic and Medicinal Chemistry. 23, 15, p. 4230-4236 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Antivascular 100%
  • Vascular Targeting Agent 95%
  • Antimitotic 79%
  • Antimitotic Agents 77%
  • KB Cells 75%
  17 引文 斯高帕斯（Scopus）

• Antimitotic and vascular disrupting agents: 2-Hydroxy-3,4,5- trimethoxybenzophenones

  Chang, C. Y., Chuang, H. Y., Lee, H. Y., Yeh, T. K., Kuo, C. C., Chang, C. Y., Chang, J. Y. & Liou, J. P., 4月 22 2014, 於: European Journal of Medicinal Chemistry. 77, p. 306-314 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Benzophenones 100%
  • Vascular Targeting Agent 95%
  • fosbretabulin 89%
  • Antimitotic 79%
  • Antimitotic Agents 77%
  9 引文 斯高帕斯（Scopus）

• Antiobesity and antihyperlipidaemic effects of Yan-Sheng-Yin in animals and humans

  Wu, C. H., Pan, C. H., Lee, C. K., Sheu, M. J., Liu, F. C., Wang, G. J. & Wu, C. H., 6月 1 2016, 於: Journal of Functional Foods. 24, p. 173-182 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • atherogenesis 100%
  • Hypolipidemic Agents 97%
  • hyperlipidemia 88%
  • Hyperlipidemias 72%
  • Atherosclerosis 58%
  1 引文 斯高帕斯（Scopus）

• Anti-obesity drug use before professional treatment in Taiwan

  Liou, T. H., Wu, C. H., Chien, S-C., Lin, W. Y., Lee, W. J. & Chou, P., 9月 2007, 於: Asia Pacific Journal of Clinical Nutrition. 16, 3, p. 580-586 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Anti-Obesity Agents 100%
  • Taiwan 68%
  • Obesity 48%
  • Plant Preparations 36%
  • Dietary Supplements 35%
  4 引文 斯高帕斯（Scopus）

• Antioxidant activities of dioscorin, the storage protein of yam (Dioscorea batatas Decne) tuber

  Hou, W. C., Lee, M. H., Chen, H. J., Liang, W. L., Han, C. H., Liu, Y. W. & Lin, Y. H., 2001, 於: Journal of Agricultural and Food Chemistry. 49, 10, p. 4956-4960 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Dioscorea polystachya 100%
  • Dioscorea 95%
  • Electron Spin Resonance Spectroscopy 80%
  • yams 74%
  • storage proteins 68%
  169 引文 斯高帕斯（Scopus）

• Antioxidant activities of trypsin inhibitor, a 33 KDa root storage protein of sweet potato (Ipomoea batatas (L.) Lam cv. Tainong 57)

  Hou, W. C., Chen, Y. C., Chen, H. J., Lin, Y. H., Yang, L-L. & Lee, M. H., 2001, 於: Journal of Agricultural and Food Chemistry. 49, 6, p. 2978-2981 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Ipomoea batatas 100%
  • Trypsin Inhibitors 82%
  • Trypsin Inhibitor 72%
  • storage proteins 66%
  • trypsin inhibitors 66%
  83 引文 斯高帕斯（Scopus）

• Antioxidant and anti-inflammatory properties of Cardiospermum halicacabum and its reference compounds ex vivo and in vivo

  Huang, M. H., Huang, S. S., Wang, B. S., Wu, C. H., Sheu, M. J., Hou, W. C., Lin, S. S. & Huang, G. J., 1月 27 2011, 於: Journal of Ethnopharmacology. 133, 2, p. 743-750 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Sapindaceae 100%
  • Antiinflammatory 53%
  • Antioxidant Agent 42%
  • Oxides 41%
  • Antioxidants 41%
  106 引文 斯高帕斯（Scopus）

• Antioxidant and heme oxygenase-1 (HO-1)-induced effects of selected Taiwanese plants

  Lee, M. H., Jiang, C. B., Juan, S. H., Lin, R. D. & Hou, W. C., 2月 2006, 於: Fitoterapia. 77, 2, p. 109-115 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Heme Oxygenase-1 100%
  • Superoxides 85%
  • 1,1-diphenyl-2-picrylhydrazyl 79%
  • Heme 78%
  • Inhibitory Concentration 50 77%
  23 引文 斯高帕斯（Scopus）

• Anti-proliferation effect of 3-amino-2-imino-3,4-dihydro-2H-1,3- benzothiazin-4-one (BJ-601) on human vascular endothelial cells: G0/G1 p21-associated cell cycle arrest

  Yu, C. H., Wu, J., Su, Y. F., Ho, P. Y., Liang, Y. C., Sheu, M. T. & Lee, W. S., 5月 15 2004, 於: Biochemical Pharmacology. 67, 10, p. 1907-1916 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • 3-amino-2-imino-3,4-dihydro-2H-1,3-benzothiazin-4-one 100%
  • Thymidine 42%
  • Cell Cycle Checkpoints 37%
  • Endothelial Cells 28%
  • Capillary Crystal 22%
  13 引文 斯高帕斯（Scopus）

• Anti-proliferation effect of 5,5-diphenyl-2-thiohydantoin (DPTH) in human vascular endothelial cells

  Shih, C. R., Wu, J., Liu, Y., Liang, Y. C., Lin, S. Y., Sheu, M. T. & Lee, W. S., 1月 1 2004, 於: Biochemical Pharmacology. 67, 1, p. 67-75 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • diphenylthiohydantoin 100%
  • Human Umbilical Vein Endothelial Cells 40%
  • Endothelial Cells 34%
  • Thymidine 34%
  • Antisense Oligonucleotide 21%
  17 引文 斯高帕斯（Scopus）

• Antipsychotic Use in Early Pregnancy and the Risk of Maternal and Neonatal Complications

  Lin, H. Y., Lin, F. J., Katz, A. J., Wang, I. T. & Wu, C. H., 11月 2022, 於: Mayo Clinic Proceedings. 97, 11, p. 2086-2096 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Antipsychotic Agents 100%
  • Mothers 69%
  • Pregnancy 66%
  • Low Birth Weight Infant 38%
  • Premature Birth 28%

• Anti-restenotic roles of dihydroaustrasulfone alcohol involved in inhibiting PDGF-BB-stimulated proliferation and migration of vascular smooth muscle cells

  Li, P. C., Sheu, M. J., Ma, W. F., Pan, C. H., Sheu, J. H. & Wu, C. H., 5月 1 2015, 於: Marine Drugs. 13, 5, p. 3046-3060 15 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • dihydroaustrasulfone alcohol 100%
  • Becaplermin 56%
  • Vascular Smooth Muscle 42%
  • Smooth Muscle Myocytes 38%
  • Cell Movement 11%
  18 引文 斯高帕斯（Scopus）

• Antiretroviral Therapy Outcomes in Malawi: Access, Mortality and Opportunistic Infections

  Kachingwe, B. H. K., Wang, L. H. & Cheng, H. W., 8月 2012, 於: Journal of Experimental and Clinical Medicine(Taiwan). 4, 4, p. 235-238 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Malawi 100%
  • Opportunistic Infections 84%
  • HIV 53%
  • Mortality 38%
  • Acquired Immunodeficiency Syndrome 32%
  1 引文 斯高帕斯（Scopus）

• Antithrombogenic oxide film on stainless steel for cardiovascular applications

  Shih, C. C., Shih, C. M., Su, Y. Y. & Lin, S. J., 10月 2004, 於: Wire Journal International. 37, 10, p. 64-69 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Stainless Steel 100%
  • Oxide films 90%
  • Amorphous films 89%
  • Stainless steel 63%
  • Protective coatings 45%
  2 引文 斯高帕斯（Scopus）

• Anti-TNF-α restricts dengue virus-induced neuropathy

  Jhan, M. K., Huangfu, W. C., Chen, Y. F., Kao, J. C., Tsai, T. T., Ho, M. R., Shen, T. J., Tseng, P. C., Wang, Y. T. & Lin, C. F., 11月 2018, 於: Journal of Leukocyte Biology. 104, 5, p. 961-968 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Dengue Virus 100%
  • Encephalitis 51%
  • Dengue 27%
  • Virus Diseases 26%
  • Neurons 14%
  16 引文 斯高帕斯（Scopus）

• Anti-UVC irradiation and metal chelation properties of 6-benzoyl-5,7-dihydroxy-4-phenyl-chromen-2-one: An implications for anti-cataract agent

  Liao, J. H., Wu, T. H., Hsu, F-L., Huang, Y. S., Chiang, P. H., Huang, Z. Y., Huang, C. H., Wu, S. H. & Lin, M. H., 10月 2011, 於: International journal of molecular sciences. 12, 10, p. 7059-7076 18 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Anti Cataract 100%
  • chelation 84%
  • Chelation 76%
  • cataracts 66%
  • Crystallins 64%
  3 引文 斯高帕斯（Scopus）

• Antrodia cinnamomea enhances chemo-sensitivity of 5-fu and suppresses colon tumorigenesis and cancer stemness via up-regulation of tumor suppressor miR-142-3p

  Huang, Y. J., Yadav, V. K., Srivastava, P., Wu, A. T. H., Huynh, T. T., Wei, P. L., Huang, C. Y. F. & Huang, T. H., 8月 1 2019, 於: Biomolecules. 9, 8, 306.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Antrodia 100%
  • 5-Fluorouracil 70%
  • Colonic Neoplasms 52%
  • Carcinogenesis 44%
  • Up-Regulation 42%
  13 引文 斯高帕斯（Scopus）

• Antroquinonol, a ubiquinone derivative from the mushroom antrodia camphorata, inhibits colon cancer stem cell-like properties: Insights into the molecular mechanism & inhibitory targets

  Lin, H. C., Lin, M. H., Liao, J. H., Wu, T. H., Lee, T. H., Mi, F. L., Wu, C. H., Chen, K. C., Cheng, C. H. & Lin, C. W., 2017, 於: Journal of Agricultural and Food Chemistry. 65, 1, p. 51-59 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • antroquinonol 100%
  • antroquinonols 99%
  • Antroquinonol 97%
  • Antrodia 81%
  • Taiwanofungus camphoratus 79%
  40 引文 斯高帕斯（Scopus）

• Antroquinonol D, isolated from Antrodia camphorata, with DNA demethylation and anticancer potential

  Wang, S. C., Li, Z-H., Hsu, C. H., Chang, Y. J., Chang, M. S., Wang, Y. C., Ho, Y. S., Wen, W. C. & Lin, R. K., 6月 18 2014, 於: Journal of Agricultural and Food Chemistry. 62, 24, p. 5625-5635 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • antroquinonol 100%
  • antroquinonols 99%
  • Antroquinonol 97%
  • Antrodia 81%
  • Taiwanofungus camphoratus 79%
  37 引文 斯高帕斯（Scopus）

• An unusual case of focal segmental glomerulosclerosis presenting with retropharyngeal edema

  Hsu, C. H., Wu, M. Y., Liu, Y. C. & Wong, C. S., 11月 1 2016, 於: European Annals of Otorhinolaryngology, Head and Neck Diseases. 133, 5, p. 355-356 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Focal Segmental Glomerulosclerosis 100%
  • Edema 62%
  • Neck 58%
  • Hypoalbuminemia 19%
  • Suppuration 18%

• An Unusual Case of Septic Pulmonary Embolism Secondary to Renal Abscess

  Hung, L. Y., Wong, C. S., Tseng, Y. C. & Wu, M. Y., 8月 2013, 於: Journal of Experimental and Clinical Medicine(Taiwan). 5, 4, p. 162-163 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A parallel-arm randomized controlled trial to assess the effects of a far-infrared-emitting collar on neck disorder

  Lin, Y. S., Hung, K. S., Liau, B. Y., Yang, C. H., Yang, A. & Huang, K. S., 2015, 於: Materials. 8, 9, p. 5862-5876 15 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Infrared radiation 100%
  • Disorder 99%
  • disorders 89%
  • Muscle 64%
  • muscles 52%
  4 引文 斯高帕斯（Scopus）

• A Pharmacist-initiated Project to Reduce Meperidine Use in Surgical Patients

  Wu, M. T., Wu, T. Y., Tai, Y-T., Chen, H. Y. & Kuo, L. N., 8月 2012, 於: Journal of Experimental and Clinical Medicine(Taiwan). 4, 4, p. 245-248 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Meperidine 100%
  • Pharmacists 76%
  • Analgesics 14%
  • Inappropriate Prescribing 12%
  • Critical Pathways 10%
  5 引文 斯高帕斯（Scopus）

• A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis

  Lee, Y. H., Tsai, Y. S., Chang, C. C., Ho, C. C., Shih, H. M., Chen, H. M., Lai, H. L., Lee, C. W., Lee, Y. C., Liao, Y. C., Yang, U. C., Cheng, T. H., Chern, Y. & Soong, B. W., 4月 2022, 於: Movement Disorders. 37, 4, p. 767-777 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • polyglutamine 100%
  • Proteostasis 99%
  • Huntington Disease 65%
  • Machado-Joseph Disease 25%
  • Huntingtin Protein 12%
  5 引文 斯高帕斯（Scopus）

• Apical Ballooning Syndrome: Case Report and Comprehensive Review of Pathogenesis

  貢獻的翻譯標題: 心尖球狀變化症候群: 病例報告及成因探討Lin, M. S., Chang, N-C., Huang, C-Y. & Shih, C-M., 2008, 於: 臺灣心臟超音波學會雜誌. 2, 2, p. 83-90 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A pilot study for circadian gene disturbance in dementia patients

  Liu, H. C., Hu, C. J., Tang, Y. C. & Chang, J. G., 4月 25 2008, 於: Neuroscience Letters. 435, 3, p. 229-233 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Methylation 100%
  • Dementia 92%
  • CpG Islands 59%
  • Genes 44%
  • Lewy Body Disease 31%
  31 引文 斯高帕斯（Scopus）

• A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab

  Chang, T. K., Yin, T. C., Su, W. C., Tsai, H. L., Huang, C. W., Chen, Y. C., Li, C. C., Chen, P. J., Ma, C. J., Chuang, K. H., Cheng, T. L. & Wang, J. Y., 2020, 於: Oncology Research. 28, 7, p. 801-809 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Silymarin 100%
  • Irinotecan 85%
  • Bevacizumab 81%
  • Colorectal Neoplasms 57%
  • Diarrhea 40%
  3 引文 斯高帕斯（Scopus）